Alessandro Parisi

2.0k total citations
56 papers, 404 citations indexed

About

Alessandro Parisi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Alessandro Parisi has authored 56 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Alessandro Parisi's work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Gastric Cancer Management and Outcomes (7 papers). Alessandro Parisi is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Gastric Cancer Management and Outcomes (7 papers). Alessandro Parisi collaborates with scholars based in Italy, United Kingdom and Austria. Alessandro Parisi's co-authors include Corrado Ficorella, Giampiero Porzio, Alessio Cortellini, Katia Cannita, Lucilla Verna, Pierpaolo Palumbo, Carlo Masciocchi, Federico Bozzetti, Davide Brocco and Nicola Tinari and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Alessandro Parisi

47 papers receiving 400 citations

Peers

Alessandro Parisi
Alessandro Parisi
Citations per year, relative to Alessandro Parisi Alessandro Parisi (= 1×) peers Stéphane Holbrechts

Countries citing papers authored by Alessandro Parisi

Since Specialization
Citations

This map shows the geographic impact of Alessandro Parisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Parisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Parisi more than expected).

Fields of papers citing papers by Alessandro Parisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Parisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Parisi. The network helps show where Alessandro Parisi may publish in the future.

Co-authorship network of co-authors of Alessandro Parisi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Parisi. A scholar is included among the top collaborators of Alessandro Parisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Parisi. Alessandro Parisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bottosso, Michele, Gaia Griguolo, Séverine Guiu, et al.. (2025). Temporal evolution of breast cancer brain metastases treatments and outcomes. npj Breast Cancer. 11(1). 20–20.
2.
Renteria, Sara Uceda, Laura Alagna, Alessandro Parisi, et al.. (2025). SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy. BMC Infectious Diseases. 25(1). 359–359.
3.
Berardi, Rossana, Alessandro Parisi, Marco Maruzzo, et al.. (2024). Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM). Supportive Care in Cancer. 32(9). 613–613. 2 indexed citations
4.
Petrelli, Fausto, Alessandro Parisi, Gianluca Tomasello, et al.. (2023). Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis. BMC Gastroenterology. 23(1). 212–212. 8 indexed citations
5.
Parisi, Alessandro, et al.. (2023). Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers. OncoTargets and Therapy. Volume 16. 585–613. 2 indexed citations
6.
Nardo, Lucia Di, Laura Del Regno, Alessandro Di Stefani, et al.. (2023). The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients. Experimental Dermatology. 32(10). 1785–1793. 4 indexed citations
7.
Zelli, Veronica, Alessandro Parisi, Katia Cannita, et al.. (2022). Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report. Frontiers in Oncology. 12. 863639–863639. 3 indexed citations
8.
Parisi, Alessandro, Michele Ghidini, Riccardo Giampieri, et al.. (2022). Post-induction Strategies in Metastatic Colorectal Cancer Patients Treated With First-Line Anti-EGFR-Based Treatment: A Systematic Review and Meta-Analysis. Clinical Colorectal Cancer. 21(3). e162–e170. 4 indexed citations
9.
Parisi, Alessandro, Giampiero Porzio, Katia Cannita, et al.. (2021). What Is Known about Theragnostic Strategies in Colorectal Cancer. Biomedicines. 9(2). 140–140. 11 indexed citations
10.
Cortellini, Alessio, Elisa Roldán, Margarita García, et al.. (2021). 1560O Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection. Annals of Oncology. 32. S1130–S1130. 3 indexed citations
11.
Fiore, Paolo Del, R Marconato, L Campana, et al.. (2021). The Role of Electrochemotherapy in the Cutaneous and Subcutaneous Metastases From Breast Cancer: Analysis of Predictive Factors to Treatment From an Italian Cohort of Patients. Frontiers in Oncology. 11. 772144–772144. 10 indexed citations
12.
Parisi, Alessandro, Alessio Cortellini, Katia Cannita, Melissa Bersanelli, & Corrado Ficorella. (2019). Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis. SHILAP Revista de lepidopterología. 2019. 1–3. 11 indexed citations
13.
14.
Parisi, Alessandro, Eleonora Palluzzi, Alessio Cortellini, et al.. (2019). First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience. Clinical & Translational Oncology. 22(1). 158–162. 18 indexed citations
15.
Cortellini, Alessio, Katia Cannita, Alessandro Parisi, et al.. (2019). <p>Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice</p>. OncoTargets and Therapy. Volume 12. 2159–2170. 5 indexed citations
16.
Cortellini, Alessio, Giampiero Porzio, Eva Katharina Masel, et al.. (2018). The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study. Palliative & Supportive Care. 17(1). 82–86. 5 indexed citations
17.
Cortellini, Alessio, Katia Cannita, Guido Collina, et al.. (2018). Where are we with treatment options after first line in small cell lung cancer?°™report of two opposite cases treated with CAPTEM regimen and possible perspectives. Journal of Thoracic Disease. 10(7). E520–E525. 1 indexed citations
18.
Watutantrige‐Fernando, Sara, Federica Vianello, Susi Barollo, et al.. (2017). The Hobnail Variant of Papillary Thyroid Carcinoma: Clinical/Molecular Characteristics of a Large Monocentric Series and Comparison with Conventional Histotypes. Thyroid. 28(1). 96–103. 39 indexed citations
19.
Cortellini, Alessio, Lucilla Verna, Katia Cannita, et al.. (2017). Topical menthol for treatment of chemotherapy-induced peripheral neuropathy. Indian Journal of Palliative Care. 23(3). 350–350. 14 indexed citations
20.
Parisi, Alessandro, et al.. (2014). Number of Mediastinal Lymph Nodes as a Prognostic Factor in PN2 Non Small Cell Lung Cancer: A Single Centre Experience and Review of the Literature. Asian Pacific Journal of Cancer Prevention. 15(18). 7559–7562. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026